Related Experiment Videos

Radioprotection by biological response modifiers alone and in combination with WR-2721

M L Patchen¹, M M D'Alesandro, M A Chirigos

¹Armed Forces Radiobiology Research Institute, Bethesda, MD 20814.

Pharmacology & Therapeutics

|January 1, 1988

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer.

Investigational new drugs·2017

Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects.

Investigational new drugs·2016

Effect of iron deficiency on the biodistribution and tumor uptake of Ga-67 citrate in animals: concise communication.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2013

Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.

Journal of applied toxicology : JAT·2001

Radioprotection by antioxidants.

Annals of the New York Academy of Sciences·2000

Kinetics of cellular and cytokine responses in a chimeric mouse model for the study of staphylococcal enterotoxin B pathogenesis.

Immunology letters·2000

See all related articles